J.R. Powell

Characterizing Frailty Status in the Systolic Blood Pressure Intervention Trial

Nicholas M. Pajewski, Jeff D. Williamson, William B. Applegate et al. · The Journals of Gerontology Series A · 2016 · 180 citations · Full text

Angiotensin-converting enzyme inhibitors. Mercaptan, carboxyalkyl dipeptide, and phosphinic acid inhibitors incorporating 4-substituted prolines

John Krapcho, Chester F. Turk, David W. Cushman et al. · Journal of Medicinal Chemistry · 1988 · 163 citations · Full text

Cardiovascular Pharmacology, Pharmacotherapy, Chemical Biology +18

Isoproterenol-Induced Cardiac Hypertrophy: Modifications in Characteristics of β-Adrenergic Receptor, Adenylate Cyclase, and Ventricular Contraction*

James Tse, J.R. Powell, CLAUDIA A. BASTE et al. · Endocrinology · 1979 · 120 citations

Cardiac Muscle, Minimal Focal Necrosis, Cardiovascular Pharmacology +19

(Phosphinyloxy)acyl amino acid inhibitors of angiotensin converting enzyme (ACE). 1. Discovery of (S)-1-[6-amino-2-[[hydroxy(4-phenylbutyl)phosphinyl]oxy]-1-oxohexyl]-L-proline, a novel orally active inhibitor of ACE

Donald S. Karanewsky, Michael C. Badia, David W. Cushman et al. · Journal of Medicinal Chemistry · 1988 · 106 citations · Full text

Pharmaceutical Science, Bioorganic Chemistry, Cardiovascular Pharmacology +16

Angiotensin-Converting Enzyme Inhibition and the Progression of Congestive Cardiomyopathy

Francis G. Spinale, Henry H. Holzgrefe, Rupak Mukherjee et al. · Circulation · 1995 · 105 citations